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Abstract
Background: Some evidences have shown the role of antioxidant vitamins in preventing 
atrial fibrillation (AF) after coronary artery bypass grafting (CABG) surgery. We sought to de-
termine the effect of oral vitamin C on the incidence of postoperative AF in patients undergoing 
elective isolated on-pump CABG surgery.
Methods: One-hundred patients who underwent isolated CABG surgery were prospectively 
assigned into two groups: Group 1 — 50 patients received 2 g of oral vitamin C before and 
500 mg twice daily lasting for 5 days after surgery; Group 2 — 50 patients as the control group 
did not receive any. All patients were continuously monitored after surgery in the intensive care 
unit (ICU), and then Holter monitoring was implemented for 72 h.
Results: The mean of patients’ age was 61.31 ± 6.42 years. Postoperative AF occurred in 
16 and 4 patients in control and treatment groups, respectively (32% vs. 8%, p = 0.003). The 
ICU stay was 1.79 ± 0.313 and 2.10 ± 0.61 days for vitamin C and control groups, respecti-
vely (p = 0.002). The hospital stay was significantly lower in vitamin C group compared with 
that of the control group (5.32 ± 0.59 vs. 5.74 ± 1.30 days, respectively, p = 0.041). Baseli-
ne erythrocyte sedimentation rate (OR 1.030, 95% CI 1.003–1.058, p = 0.030) and taking 
vitamin C (OR 8.068, 95% CI 1.783–36.517, p = 0.007) were the independent predictors of 
postoperative AF.
Conclusions: Oral vitamin C can be safely used to decrease the incidence of postoperative AF in 
patients undergoing elective isolated on-pump CABG surgery. (Cardiol J 2014; 21, 5: 492–499)
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Introduction
Atrial fibrillation (AF) is the most common 
sustained cardiac arrhythmia in clinical practice 
with the estimated prevalence of 0.4% to 1%, 
advancing with age [1–4]. The lifetime risk of AF 
development in both sexes is estimated to be 25%, 
that is showing the need for further investigation to 
elucidate preventive strategies, predisposing fac-
tors and treatments for this public health problem 
[5]. AF is indicative of cardiac diseases progression 
that is associated with increased long-term risk 
of stroke and mortality. Some factors were found 
to predispose patients to AF that include advan-
ced age, diabetes mellitus (DM), hypertension, 
smoking, valvular heart disease, prior myocardial 
infarction (MI), congestive heart failure (CHF), 
left ventricular hypertrophy and decreased left 
ventricular ejection fraction (LVEF) [1, 6].
AF is also the commonest cardiac rhythm distur-
bance following cardiac surgeries, with the exception 
of sinus tachycardia [7]. The incidence of postopera-
tive AF differs between cardiac surgeries as it has 
been found to be about 30% in patients undergoing 
coronary artery bypass grafting (CABG) surgery 
alone, and about 60% in those undergoing combined 
CABG and valve surgeries [7–9]. Postoperative AF 
is a substantial factor for developing morbidity and 
mortality following cardiac surgery [8, 10, 11], and 
it has been shown that it contributes to the increase 
in the length of hospital stay and intensive care unit 
(ICU) stay following isolated CABG surgery [12].
The fundamental mechanism involved in 
developing postoperative AF has been shown to 
be multifactorial. It has been investigated that 
inflammation and oxidative stress attributable to is-
chemia/reperfusion events in the setting of CABG 
surgery result in electrophysiological remodeling 
of atrium, and these are the main etiologies for 
the occurrence of postoperative AF [13]. Given 
these points in terms of etiologies, few studies 
have demonstrated the effect of antioxidant agents 
including vitamins C and E on the incidence of 
postoperative AF [14]. Hereby, we conducted a ran-
domized clinical trial to evaluate the effect of oral 
vitamin C on the incidence of AF following elective 
isolated on-pump CABG surgery, and, also, on the 
length of hospital and ICU stays after the surgery.
Methods
Patients and protocols 
The patients who underwent elective isolated 
on-pump CABG surgery in our institution, Seyyed-
-al-Shohada Heart Center, form March 2012 to 
March 2013, were randomly assigned to receive 
either oral vitamin C, treatment group, or no agent, 
control group. This study was approved by our 
local ethical committee in the Urmia University of 
Medical Sciences; all patients were informed and 
given their written consent.
The inclusion criteria were as follows: age 
> 50 years, without history of CABG surgery, 
isolated on-pump CABG surgery, and taking beta-
-blocker agents before and after surgery. Exclusion 
criteria were as follows: history of any cardiac 
arrhythmia and/or being under anti-arrhythmic 
therapy, being under digoxin therapy, having pa-
cemaker, severe CHF and/or LVEF < 30%, renal 
failure (creatinine ≥ 1.5 mg/dL), severe hepatic 
failure, chronic obstructive pulmonary disease, no 
occurrence of intra- or post-operative cardiopulmo-
nary arrest, or any degree of cardiac blockade and/
or bradycardia < 50 bpm.
Considering Eslami et al. [15] study showing 
the incidence of postoperative AF 26% and 4% in 
the vitamin C and control groups, respectively, 
and 95% confidence interval (CI) with the power 
of 80%, our sample size was calculated as appro-
ximately 50 patients per group. Consequently, 
100 patients who met our study inclusion criteria were 
allocated into groups. All patients were randomized 
into two groups in a 1:1 ratio using random-number 
table. The groups included: Group 1 — 50 patients 
who were given 2 g of vitamin C tablets before the 
surgery and 500 mg twice daily for 5 days after the 
surgery; Group 2 — 50 patients as control group, 
were not given any drug. All patients also recei-
ved beta-blockers 1 week before the surgery and 
continued after the surgery.
Clinical characteristics including age, gender, 
risk factors history, drugs history, echocardiogra-
phic examination, and laboratory measurements 
were collected. Drug history was defined as those 
agents which were consumed at least 1 week before 
the surgery. Hypertension was defined as those 
who had systolic blood pressure ≥ 140 mm Hg 
and diastolic blood pressure ≥ 90 mm Hg and/or 
taking antihypertensive medicines. Hyperlipidemia 
was defined as those who either had low-density 
lipoprotein > 100 mg/dL or were under therapy for 
hyperlipidemia. DM was diagnosed as those who 
had one of the following criteria; 1) the symptoms 
of diabetes plus plasma glucose concentration 
> 200 mg/dL; 2) fasting plasma glucose ≥ 126 mg/dL; 
3) 2-h post-loading glucose ≥ 200 mg/dL during an 
oral glucose tolerance test; and/or 4) consuming 
anti-diabetic drugs.
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Echocardiography was performed by a single 
echocardiographer and some measurements inclu-
ding LVEF, left atrium diameter, and left ventricular 
end-systolic and end-diastolic diameters were cal-
culated upon echocardiographic evaluation. Blood 
samples were collected 6 to 24 h before the sur-
gery to assess hematologic parameters including 
white blood cell count, hemoglobin, hematocrit 
and erythrocyte sedimentation rate (ESR). All 
patients underwent on-pump CABG surgery using 
standard cardiopulmonary bypass by a single sur-
gical team. CABG-related characteristics including 
the number of grafts used, the duration of aortic 
cross-clamp, the duration of pump perfusion and 
the duration of postoperative ventilation were also 
recorded.
All patients were continuously monitored after 
surgery using a wearable health monitoring in the 
ICU, and then monitored using an electrocardio-
graphic Holter monitoring for 72 h in the ward. 
Postoperative AF was defined as patients who 
had an episode of AF lasting more than 10 min. 
Amiodarone was intravenously used to control 
fibrillation rhythm and conversion to sinus rhythm 
(SR) and was continued orally during a 6-week 
period. Wearable continuous monitoring and elec-
trocardiographic Holter monitoring was assessed 
by a single cardiac electrophysiologist.
Statistical analysis
Categorical variables were presented as 
number (percentage) and analyzed using c2 or 
Fisher’s exact tests, as appropriate. Continuous 
variables were evaluated using Student’s t-test 
or Mann-Whitney U test, as appropriate. For 
identifying the diagnostic value of laboratory, 
a receiver operating characteristic (ROC) curve 
was conducted. Multivariate analysis, binary lo-
gistic regression, were also used to detect the 
independent predictors of postoperative AF. In this 
model, covariates included the variables which pro-
ved significant or p < 0.1 in the univariate analysis. 
P values less than 0.05 were considered statisti-
cally significant. All analyses were performed by 
SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).
Results
One-hundred (100%) patients completed this 
study; in each group there were 50 patients, the 
two groups were the vitamin C group and the con-
trol group. The mean age of patients was 61.31 ± 
± 6.42 years, and the majority of them (74%) were 
male. The baseline and CABG-related characteri-
stics of both groups are shown in Table 1. There 
were no significant differences between the groups 
regarding measured baseline and CABG-related 
characteristics (Table 1).
Postoperative AF occurred in 20 (20%) pa-
tients; its incidence were 16 and 4 patients in 
control and treatment groups, respectively (32% 
vs. 8%, p = 0.003). The mean length of postope-
rative AF incidence was 2.55 ± 1.15 days, and its 
mean for the treatment group was 2 ± 0.816 days 
vs. 2.69 ± 1.195 days for the control group (p = 
= 0.295). The majority of postoperative AFs were 
seen at 2nd and 3rd days, however it did not show any 
significant differences between the groups (Fig. 1). 
The time needed for converting AF to SR was 
not significantly different among groups, although 
its value was considerably lower in the vitamin C 
compared with the control group (3.37 ± 1.03 vs. 
14 ± 28.95 h, p = 0.395) (Table 2).
No significant difference regarding the begin-
ning location of postoperative AF, ICU or ward, was 
observed (Table 2). The total mean length of ICU 
stay was 1.95 ± 0.51 days, and this time was 1.79 ± 
± 0.313 days for vitamin C and 2.10 ± 0.61 days 
for control group (p = 0.002). The mean length 
of hospital stay was 5.53 ± 1.03 days, and it was 
significantly lower in vitamin C compared with 
control group (5.32 ± 0.59 vs. 5.74 ± 1.30 days, 
respectively, p = 0.041). The mean of ICU stay was 
1.80 ± 0.30 days in the patients who developed 
AF postoperatively and 2.56 ± 0.69 days in those 
who had SR postoperatively (p = 0.001). The mean 
of hospital stay was 5.25 ± 0.50 vs. 6.65 ± 1.70 
days in the patients with AF and SR, respectively 
(p = 0.001).
The predictors of developing postoperative AF 
were listed in Tables 3 and 4. Based on univariate 
analysis, having DM, prolonged ventilation time 
and increased ESR were the main risk factors for 
developing postoperative AF. In addition, a trend 
was observed that patients with AF were older 
and had lower amount of LVEF than those with 
SR (Tables 3, 4).
The ROC curve was drawn for detecting ESR 
diagnostic value (Fig. 2). The area under the curve 
(AUC) was 0.710 (95% CI 0.574–0.846, p = 0.005). 
The best cut-off point was 27.5 mm/h with the sensi-
tivity and specificity of 63% and 71%, respectively.
Logistic regression model showed that the 
baseline ESR value (odd ratio [OR] 1.030, 95% CI 
1.003–1.058, p = 0.030) and taking vitamin C (OR 
8.068, 95% CI 1.783–36.517, p = 0.007) were the 
independent predictors of developing postoperative 
AF (Table 5). Hosmer-Lemeshow test of goodness 
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of fit the model showed high predictive value with 
p value of 0.993.
Moreover, a case of stroke occurred in one of 
the control group’s patient who had been develo-
ping AF at the first day after the CABG surgery 
(Table 2).
Discussion
In the present investigation, in accordance 
with previous studies regarding the effect of an-
tioxidants on the occurrence of postoperative AF, 
we showed that oral vitamin C, as an antioxidant 
agent, led to decrease in the incidence of postope-
rative AF and the length of ICU stay and length of 
hospital stay in the patients who underwent elec-
tive isolated on-pump CABG surgery. Univariate 
analysis showed that DM, increased ventilation 
time, and increased baseline ESR were the main 
Table 1. Baseline and coronary artery bypass grafting-related characteristics of study cohort.
Total  
(n = 100)
Vitamin C  
(n = 50)
Control  
(n = 50)
P 
Age [years] 61.31 ± 6.42 60.52 ± 5.83 62.12 ± 6.93 0.215
Sex (male) 74 (74%) 38 (76%) 36 (72%) 0.648
Hypertension 30 (30%) 14 (28%) 16 (32%) 0.663
Diabetes mellitus 24 (24%) 9 (18%) 15 (30%) 0.160
Hypercholesterolemia 15 (15%) 9 (18%) 6 (12%) 0.401
Smoking 21 (21%) 12 (24%) 9 (18%) 0.461
Myocardial infarction 21 (21%) 11 (22%) 10 (20%) 0.806
Nitrate use before CABG 37 (37%) 17 (34%) 21 (42%) 0.410
Nitrate use after CABG 96 (96%) 47 (94%) 49 (98%) 0.307
Statin use before CABG 16 (16%) 9 (18%) 7 (14%) 0.585
Statin use after CABG 18 (18%) 10 (20%) 8 (16%) 0.603
Left atrial diameter [cm] 19.37 ± 2.60 19.72 ± 2.42 19.02 ± 2.75 0.180
LVEF [%] 43.30 ± 8.17 43.6 ± 8.15 43 ± 8.27 0.716
LVEF < 30% 10 (10%) 4 (8%) 6 (12%) 0.505
LV end-systolic diameter [cm] 3.08 ± 0.65 3.05 ± 0.66 3.10 ± 0.64 0.668
LV end-diastolic diameter [cm] 4.67 ± 0.73 4.55 ± 0.68 4.77 ± 0.77 0.136
Number of grafted vessels 2.79 ± 0.56 2.80 ± 0.57 2.78 ± 0.54 0.858
Aortic cross-clamp time [min] 75.50 ± 23.30 77.44 ± 24.07 73.56 ± 22.58 0.408
Perfusion pump time [min] 116.25 ± 30.13 118.64 ± 29.71 113.86 ± 30.66 0.430
Ventilation time [h] 14.40 ± 10.25 13.38 ± 2.01 15.41 ± 14.35 0.325
Ventilation > 24 h 1 (1%) 0 (0%) 1 (2%) 1
Blood transfusion before CABG [U] 0.92 ± 1.06 0.88 ± 1.06 0.96 ± 1.07 0.708
Blood transfusion after CABG [U] 0.69 ± 1.13 0.66 ± 1.14 0.72 ± 1.14 0.739
Central venous pressure [cm] 5.22 ± 1.77 5.28 ± 1.77 5.16 ± 1.8 0.737
White blood cell (×103) 7.29 ± 2.11 7.33 ± 2.13 7.24 ± 2.09 0.837
Erythrocyte sedimentation rate [mm/h] 26.27 ± 24.07 27.52 ± 25.09 24.96 ± 23.16 0.601
Hemoglobin [mg/dL] 13.08 ± 1.61 12.95 ± 1.72 13.21 ± 1.49 0.431
Hematocrit [%] 39.40 ± 4.55 39.36 ± 4.60 39.43 ± 4.54 0.938
CABG — coronary artery bypass grafting; LV — left ventricular; LVEF — left ventricular ejection fraction
Figure 1. Time of first incidence of postoperative atrial 
fibrillation (AF) in those who received vitamin C vs. 
control group.
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Table 2. Measured outcomes of study following coronary artery bypass grafting.
Total  
(n = 100)
Vitamin C  
(n = 50)
Control  
(n = 50)
P 
Postoperative AF 20 (20%) 4 (8%) 16 (32%) 0.003
Day of postoperative AF [days] 2.55 ± 1.15 2 ± 0.816 2.69 ± 1.195 0.295
Location of postoperative AF occurrence: 0.639
ICU 7 (35%) 1 (25%) 6 (37.5%)
Ward 13 (65%) 3 (75%) 10 (62.5%)
Duration of rhythm conversion [h] 11.87 ± 26.10 3.37 ± 1.03 14 ± 28.95 0.395
ICU stay [days] 1.95 ± 0.51 1.79 ± 0.313 2.10 ± 0.61 0.002
Hospital stay [days] 5.53 ± 1.03 5.32 ± 0.59 5.74 ± 1.30 0.041
Cerebrovascular events 1 (1%) 0 (0%) 1 (2%) 1
AF — atrial fibrillation; ICU — intensive care unit
Table 3. Univariate analysis of qualitative predictors of postoperative atrial fibrillation (AF).
AF in variable positive AF in variable negative P 
Sex (male) 16/74 (21.6%) 4/26 (15.4%) 0.494
Hypertension 7/30 (23.3%) 13/70 (18.6%) 0.585
Diabetes mellitus 10/24 (41.7%) 10/76 (13.2%) 0.002
Hypercholesterolemia 3/15 (20%) 17/85 (20%) 1
Smoking 4/21 (19%) 16/79 (20.3%) 0.902
Myocardial infarction 5/21 (23.8%) 15/79 (19%) 0.623
Nitrate use before CABG 6/38 (15.8%) 14/62 (22.6%) 0.410
Nitrate use after CABG 20/96 (20.8%) 0/4 (0%) 0.307
Statin use before CABG 3/16 (18.8%) 17/84 (20.2%) 0.892
Statin use after CABG 4/18 (22.2%) 16/82 (19.5%) 0.795
LVEF < 30% 4/10 (40%) 16/90 (17.8%) 0.096
Ventilation > 24 h 1/1 (100%) 0/99 (0%) 0.200
CABG — coronary artery bypass grafting; LVEF — left ventricular ejection fraction
Table 4. Univariate analysis of quantitative predictors of postoperative atrial fibrillation.
Atrial fibrillation Sinus rhythm P 
Age [years] 63.75 ± 6.24 60.71 ± 6.36 0.058
Left atrial diameter [cm] 19.25 ± 2.86 19.40 ± 2.55 0.819
LVEF [%] 40.25 ± 8.50 44.06 ± 7.95 0.062
LV end-diastolic diameter [cm] 3.04 ± 0.57 3.08 ± 0.67 0.781
LV end-systolic diameter [cm] 4.45 ± 0.74 4.72 ± 0.73 0.142
Number of grafted vessels 2.65 ± 0.74 2.82 ± 0.50 0.210
Aortic cross-clamp time [min] 72.85 ± 17.06 76.16 ± 24.66 0.572
Perfusion pump time [min] 112.95 ± 20.34 117.08 ± 32.17 0.587
Ventilation time [h] 19.36 ± 22.39 13.15 ± 1.80 0.015
Blood transfusion before CABG [U] 0.6 ± 0.68 1 ± 1.025 0.132
Blood transfusion after CABG [U] 1 ± 1.49 0.61 ± 1.025 0.173
Central venous pressure [cm] 5.65 ± 1.56 5.11 ± 1.81 0.227
White blood cell (× 103) 7.21 ± 2.03 7.31 ± 2.13 0.858
Erythrocyte sedimentation rate [mm/h] 42.58 ± 29.74 22.34 ± 20.88 0.001
Hemoglobin [mg/dL] 12.78 ± 2.22 13.16 ± 1.42 0.348
Hematocrit [%] 40.08 ± 5.26 39.23 ± 4.37 0.459
CABG – coronary artery bypass grafting; LV — left ventricular; LVEF — left ventricular ejection fraction
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risk factors for postoperative AF. Furthermore, 
it showed a trend toward a higher incidence of 
postoperative AF in aging patients and those with 
decreased LVEF. All baseline and perioperative 
characteristics were similar between groups and 
the study cohort was homogenous. Consequently, 
we may be able to state that these findings are due 
to the effect of vitamin C, not any other factors 
which have an impact on the incidence of AF after 
CABG surgery.
AF as the commonest arrhythmia after cardiac 
surgery is usually developed during 2 or 3 days 
postoperatively [8], in our study the most of AF 
occurred on the 2nd and 3rd  days after the surgery 
(Fig. 1). The recent studies have shown that the 
postoperative AF correlated with decreased survi-
val and increased in-hospital adverse events during 
short- and long-term follow-up [16–18]. Despite 
conducting more investigations regarding posto-
perative AF pathogenesis, its mechanism has not 
been identified yet [19]. Increasing evidences exist 
that have demonstrated the oxidative stress and 
inflammation as the main etiologies for developing 
AF after cardiac surgery. It has been previously 
found that the increased sympathetic tone due 
to surgical trauma and injury owing to ischemia/ 
/reperfusion during CABG surgery resulting in trig - 
gering oxidative stress have important role in the 
electrophysiological remodeling of atrial myocytes 
and consequent AF genesis [2]. Additionally, the 
substantial impact of vitamin C may be attributed 
to decreasing peroxynitrite formation and increase 
in intracellular ascorbate levels, as well [2]. Hence, 
we prescribed beta-blockers pre- and post-opera-
tively to all patients to decrease the sympathetic 
effect on atrial remodeling, and then examined the 
antioxidant ability of vitamin C in reducing AF by 
controlling oxidative stress mediated processes.
Eslami et al. [15] have found that adding vi-
tamin C to beta-blocker regimen before and after 
isolated CABG resulted in decreased postoperative 
AF in the combination group compared with beta-
-blocker usage alone (4% vs. 26%, respectively), 
however it did not reduce the length of ICU and 
hospital stays. Another study has investigated the 
role of oral ascorbic acid in the attenuation of po-
stoperative AF in patients who underwent CABG, 
and interestingly led to decrease in AF occurrence 
from 34.9% for control to 16.4% for vitamin C group 
[2]. The study of Papoulidis et al. [20] has indicated 
that taking vitamin C reduced the rate of AF in 
comparison with not taking any (44.7% vs. 61.2%). 
They also found significant decreases in the time 
of AF conversion to SR (7.3 ± 2.1 h in control vs. 
5 ± 1.3 h in vitamin C group), and the length of 
hospital stay (9.5 ± 2.8 days in control vs. 6.7 ± 1.9 
days in treatment group). These findings are 
consistent with our study showing the efficacy of 
vitamin C in preventing postoperative AF, however, 
Table 5. Logistic regression analysis detecting independent predictors of postoperative atrial fibrillation.
Exp (B) 95% confidence interval for Exp (B) P 
Age 1.005 0.907–1.114 0.925
Diabetes mellitus 1.613 0.399–6.525 0.503
Ventilation time 1.272 0.893–1.811 0.182
Left ventricular ejection fraction 0.960 0.890–1.036 0.291
Erythrocyte sedimentation rate 1.030 1.003–1.058 0.030
Vitamin C use 8.068 1.783–36.517 0.007
Figure 2. Receiver operating characteristics curve of 
erythrocyte sedimentation rate for identifying postope-
rative atrial fibrillation; AUC — area under the curve; 
CI — confidence interval.
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the present study for the first time showed the 
impact of vitamin C on reducing the length of ICU 
stay. In contrast, in the latest published placebo-
-controlled clinical trial, Bjordahl et al. [21] have 
concluded that there was no difference in posto-
perative AF incidence among patients who were 
given supplementation of vitamin C compared with 
those who were given placebo (30.3% vs. 30.2%, 
respectively; p = 0.985). It seems that the risk 
factors involved in the occurrence of postoperative 
AF and selection bias are the main factors which 
underlie paradoxical findings.
Considering inflammatory processes involved 
in postoperative AF, the markers of inflammation 
may be of importance in diagnosing and/or risk 
stratification of such patients. Accordingly, Ishi-
da et al. [22] have noted that C-reactive protein 
(CRP), interleukin-6 (IL-6) and IL-8 increased 
after off-pump CABG surgery, but IL-6 was only 
significantly different between patients with and 
without postoperative AF, and it was an indepen-
dent predictor of postoperative AF occurrence. 
Patients with an increased baseline CRP value have 
also been found to be in higher risk for developing 
AF after on- and off-pump CABG surgery [23]. 
White blood cell count is another marker that has 
been investigated and both pre- and post-operative 
increased values were the independent predictors 
of AF incidence following cardiac surgery [24, 25]. 
ESR is an inexpensive marker for acute phase re-
sponse accompanied with diagnostic and prognostic 
values, especially in the rheumatic diseases and 
newly found non-inflammatory conditions such as 
stork and coronary artery disease [26, 27]. In our 
study, for the first time, we showed that increased 
baseline ESR was a risk factor for AF development, 
and also based on multivariate analysis it was an in-
dependent predictor of postoperative AF, although 
it had partially low sensitivity and specificity. Mo-
reover, the chronic inflammation due to DM and 
coronary artery disease in patients may be another 
causes leading to increased ESR value. Further 
evaluations regarding ESR change after surgery 
may be of benefit, however, CRP and other newly 
developed inflammatory markers are more useful 
than ESR [28].
DM and decreased LVEF have been proposed 
to be the predictors of AF development [4, 6], and 
the need for prolonged ventilation (24 h or more) 
has also been shown to be an AF independent 
predictor [29]. In our study, univariate analysis 
showed that DM and increased ventilation time 
were the correlates of postoperative AF (p = 0.002, 
p = 0.015, respectively). Additionally, aging is 
one of the main predictors of AF development as 
its prevalence becomes 2-fold with each decade 
of age advancing, and males have 1.5-fold greater 
risk for developing AF than women [4]. In the 
present study, despite no significant differences 
in terms of age and gender between patients with 
AF and those with SR, there was a trend toward 
patients with AF to be older (63.75 ± 6.24 years 
vs. 60.71 ± 6.36 years, p = 0.058), and also there 
was a higher incidence of AF in men than women 
(21.6% vs. 15.4%, p = 0.494). We believe that the 
sample size of our study may be the main reason 
for our inability to show more correlates of AF 
development. Further evaluations will be helpful 
to clarify these notions.
Limitations of the study
This study has some limitations. First, it was 
not placebo-controlled trial, and had a relatively 
small sample size, which resulted in inability to 
identify postoperative AF correlates, however, we 
determined the sample size using previous study 
[15]. Surprisingly, significant results in terms of 
vitamin C impacts are promising for future pre-
ventive protocols. Second, we did not measure 
laboratory data including white blood cell count, 
hemoglobin, hematocrit and ESR after surgery, 
and if we measured postoperatively, we could find 
more interesting results.
Conclusions
Oral vitamin C can be used safely and efficacio-
usly to decrease the incidence of postoperative AF 
in patients undergoing elective isolated on-pump 
CABG surgery. Furthermore, increased baseline 
ESR and taking vitamin C were the independent 
predictors of AF development after CABG surgery.
Conflict of interest: None declared
References
1.  Fuster V, Ryden LE, Cannom DS et al. 2011 ACCF/AHA/HRS 
focused updates incorporated into the ACC/AHA/ESC 2006 Gu-
idelines for the management of patients with atrial fibrillation: 
A report of the American College of Cardiology Foundation/
American Heart Association Task Force on Practice Guidelines 
developed in partnership with the European Society of Car-
diology and in collaboration with the European Heart Rhythm 
Association and the Heart Rhythm Society. J Am Coll Cardiol, 
2011; 57: e101–e198.
2.  Carnes CA, Chung MK, Nakayama T et al. Ascorbate attenua-
tes atrial pacing-induced peroxynitrite formation and electrical 
remodeling and decreases the incidence of postoperative atrial 
fibrillation. Circ Res, 2001; 89: E32–E38.
498 www.cardiologyjournal.org
Cardiology Journal 2014, Vol. 21, No. 5
3.  Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed 
atrial fibrillation in adults: National implications for rhythm ma-
nagement and stroke prevention: The AnTicoagulation and Risk 
Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001; 285: 
2370–2375.
4.  Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, inciden-
ce, prognosis, and predisposing conditions for atrial fibrillation: 
Population-based estimates. Am J Cardiol, 1998; 82: 2N–9N.
5.  Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for de-
velopment of atrial fibrillation: The Framingham Heart Study. 
Circulation, 2004; 110: 1042–1046.
6.  Andrews M, Nelson BP. Atrial fibrillation. Mt Sinai J Med, 2006; 
73: 482–492.
7.  Hakala T, Hedman A. Predicting the risk of atrial fibrillation after 
coronary artery bypass surgery. Scand Cardiovasc J, 2003; 37: 
309–315.
8.  Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after 
cardiac surgery. Ann Intern Med, 2001; 135: 1061–1073.
9.  Banach M, Kourliouros A, Reinhart KM et al. Postoperative atrial 
fibrillation: What do we really know? Curr Vasc Pharmacol, 2010; 
8: 553–572.
10.  Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards 
of postoperative atrial arrhythmias. Ann Thorac Surg, 1993; 56: 
539–549.
11.  Almassi GH, Schowalter T, Nicolosi AC et al. Atrial fibrillation 
after cardiac surgery: A major morbid event? Ann Surg, 1997; 
226: 501–511; discussion 511–513.
12.  Borzak S, Tisdale JE, Amin NB et al. Atrial fibrillation after by-
pass surgery: Does the arrhythmia or the characteristics of the 
patients prolong hospital stay? Chest, 1998; 113: 1489–1491.
13.  Elahi MM, Flatman S, Matata BM. Tracing the origins of postope-
rative atrial fibrillation: The concept of oxidative stress-mediated 
myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil, 
2008; 15: 735–741.
14.  Rodrigo R, Vinay J, Castillo R et al. Use of vitamins C and E as 
a prophylactic therapy to prevent postoperative atrial fibrillation. 
Int J Cardiol, 2010; 138: 221–228.
15.  Eslami M, Badkoubeh RS, Mousavi M et al. Oral ascorbic acid in 
combination with beta-blockers is more effective than beta-blo-
ckers alone in the prevention of atrial fibrillation after coronary 
artery bypass grafting. Tex Heart Inst J, 2007; 34: 268–274.
16.  El-Chami MF, Kilgo P, Thourani V et al. New-onset atrial fibril-
lation predicts long-term mortality after coronary artery bypass 
graft. J Am Coll Cardiol, 2010; 55: 1370–1376.
17.  Saxena A, Dinh DT, Smith JA, Shardey GC, Reid CM, Newcomb AE. 
Usefulness of postoperative atrial fibrillation as an independent 
predictor for worse early and late outcomes after isolated corona-
ry artery bypass grafting (multicenter Australian study of 19,497 
patients). Am J Cardiol, 2012; 109: 219–225.
18.  Girerd N, Magne J, Pibarot P, Voisine P, Dagenais F, Mathieu P. 
Postoperative atrial fibrillation predicts long-term survival after 
aortic-valve surgery but not after mitral-valve surgery: A retro-
spective study. BMJ Open, 2011; 1: e000385.
19.  Rasoli S, Kakouros N, Harling L et al. Antioxidant vitamins in the 
prevention of atrial fibrillation: What is the evidence? Cardiol Res 
Pract, 2011; 164078.
20.  Papoulidis P, Ananiadou O, Chalvatzoulis E et al. The role of 
ascorbic acid in the prevention of atrial fibrillation after elective 
on-pump myocardial revascularization surgery: A single-center 
experience. A pilot study. Interact Cardiovasc Thorac Surg, 2011; 
12: 121–124.
21.  Bjordahl PM, Helmer SD, Gosnell DJ, Wemmer GE, O’Hara WW, 
Milfeld DJ. Perioperative supplementation with ascorbic acid 
does not prevent atrial fibrillation in coronary artery bypass graft 
patients. Am J Surg, 2012; 204: 862–867; discussion 867.
22.  Ishida K, Kimura F, Imamaki M et al. Relation of inflammatory 
cytokines to atrial fibrillation after off-pump coronary artery 
bypass grafting. Eur J Cardiothorac Surg, 2006; 29: 501–505.
23.  Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive 
protein is a risk indicator for atrial fibrillation after myocardial 
revascularization. Ann Thorac Surg, 2005; 79: 1530–1535.
24.  Fontes ML, Amar D, Kulak A et al. Increased preoperative white 
blood cell count predicts postoperative atrial fibrillation after co-
ronary artery bypass surgery. J Cardiothorac Vasc Anesth, 2009; 
23: 484–487.
25.  Lamm G, Auer J, Weber T, Berent R, Ng C, Eber B. Postoperative 
white blood cell count predicts atrial fibrillation after cardiac 
surgery. J Cardiothorac Vasc Anesth, 2006; 20: 51–56.
26.  Sox HC Jr, Liang MH. The erythrocyte sedimentation rate. 
Guide lines for rational use. Ann Intern Med, 1986; 104: 515–523.
27.  Saadeh C. The erythrocyte sedimentation rate: Old and new 
clinical applications. South Med J, 1998; 91: 220–225.
28.  Brigden ML. Clinical utility of the erythrocyte sedimentation 
rate. Am Fam Physician, 1999; 60: 1443–1450.
29.  Magee MJ, Herbert MA, Dewey TM et al. Atrial fibrillation after 
coronary artery bypass grafting surgery: Development of a pre-
dictive risk algorithm. Ann Thorac Surg, 2007; 83: 1707–1712; 
discussion 1712.
www.cardiologyjournal.org 499
Mohammad Reza Dehghani et al., Vitamin C and post-CABG atrial fibrillation
